Compounds > cyclohexanol
Page last updated: 2024-08-18

cyclohexanol and Depression

cyclohexanol has been researched along with Depression in 166 studies

Research

Studies (166)

TimeframeStudies, this research(%)All Research%
pre-19901 (0.60)18.7374
1990's17 (10.24)18.2507
2000's65 (39.16)29.6817
2010's80 (48.19)24.3611
2020's3 (1.81)2.80

Authors

AuthorsStudies
Croarkin, PE; Mills, JA; Strawn, JR; Suresh, V1
Asami, Y; Boucher, M; Kato, M; Pappadopulos, E; Prieto, R; Wajsbrot, DB; Wang, X1
Norman, TR; Olver, JS2
Berk, M; Bousman, CA; Byron, K; Ng, CH; Singh, AB1
Assié, MB; Auclair, AL; Bardin, L; Cussac, D; Depoortère, R; Heusler, P; Marien, M; Martel, JC; Newman-Tancredi, A; O'Connor, JA1
Buckley, G; Fayyad, R; Focht, K; Guico-Pabia, CJ; Kane, CP; Lobello, K; Nichols, AI; Preskorn, SH1
Balasubramani, GK; Daly, E; Gaynes, BN; Kurian, BT; Lesser, I; Morris, DW; Nierenberg, AA; Rush, AJ; Trivedi, MH; Wisniewski, SR1
Catlow, JT; Ding, C; Gleason, SD; Heinz, B; Leucke, S; Li, X; Lynch, RA; Thompson, LK; Witkin, JM1
Araújo, PV; da Silva, JC; de Oliveira, SL; de Sousa, CN; Macêdo, DS; Sampaio, LR; Silva, MC; Sousa, FC; Vasconcelos, SM; Ximenes, NC1
Berk, M; Dodd, S; Kelin, K; Mancini, M; Schacht, A1
Chen, W; Li, X; Wu, H; Xing, B; Yu, E1
Charoenphandhu, J; Charoenphandhu, N; Lapmanee, S1
Barbui, C; Godman, B; Gustafsson, LL; Miranda, J; Persson, M; Skiöld, P; Wettermark, B1
Bech, BH; Christensen, J; Kjaersgaard, MI; Olsen, J; Parner, ET; Pedersen, LH; Sørensen, MJ; Vestergaard, M1
Bao, W; Guico-Pabia, CJ; Ninan, PT; Shelton, RC1
Bognár, Z; Gazdag, G; Vonyik, G1
Altman, RB; Klein, TE; Sangkuhl, K; Stingl, JC; Turpeinen, M1
Chen, Y; Gan, J; Tan, Q; Wang, H; Xue, Y; Zhang, L; Zhang, R; Zhang, Y1
Charlier, P; Falissard, B; Maria, AS; Millet, B; Naudet, F; Reymann, JM1
Miller, MC1
Davidson, RJ; Heller, AS; Johnstone, T; Kalin, NH; Kolden, GG; Peterson, MJ1
Berm, EJ; Hak, E; Mulder, H; Risselada, AJ; Wilffert, B1
Preskorn, SH1
Ali, J; Baboota, S; Haque, S; Md, S; Sahni, JK1
Deckert, J; Hempel, S; Pfuhlmann, B; Proft, F; Reif, A; Riederer, P; Unterecker, S1
Bombardier, CH; Brooks, L; Bryce, TN; Chiodo, A; Dijkers, MP; Fann, JR; Forchheimer, M; Richards, JS; Tate, DG1
Auinger, P; Christine, CW; Factor, SA; Juncos, J; Leentjens, AF; Lyness, JM; Marsh, L; McDonald, W; Moonen, AJ; Panisset, M; Pfeiffer, R; Richard, IH; Rottenberg, D; Serrano Ramos, C; Shulman, L; Singer, C; Slevin, J; Wijers, A1
Guo, H; Guo, W; Hartle, K; He, J; Huang, Q; Kong, J; Li, XM; Qiao, J; Wang, H; Wang, J; Zhang, H; Zhang, Y; Zhu, S1
Boucher, M; Endicott, J; Fayyad, R; Guico-Pabia, CJ; Hsu, MA; Lam, RW1
Dew, MA; Karp, JF; Rej, S1
Huang, X; Ji, JL; Li, C; Mao, YS; Wang, H2
Hou, J; Meng, Q; Tian, J; Wu, Y; Xing, Y; Yang, M; Zuo, D1
Chen, J; Gong, W; Li, Z; Mu, J; Shao, W; Wu, Q; Xie, P; Xu, F; Yang, D; Yang, J; Yang, Y; Zhang, J1
Ivanets, NN; Iziumina, TA; Kinkulkina, MA; Tikhonova, YG1
Liu, Q; Meng, X; Shao, J; Tian, J; Wang, H; Ye, L; Zhang, F; Zhong, Y1
Domingues, DS; Miranda, LF; Queiroz, ME1
Kelly, BD1
Dhir, A; Kulkarni, SK3
Bootzin, E; Millan, MJ; O'Donnell, JM; Zhang, HT; Zhao, Z1
Carrillo, F; Johnson, J; Laustsen, G; Smith, C1
Joeris, A; Kessler, U; Nelle, M; Schwendener Scholl, K; Treichel, M1
Díaz, A; Pazos, A; Rodríguez-Gaztelumendi, A; Rojo, ML1
Il'ina, NA2
Begré, S; Gerber, M; Traber, M; von Känel, R2
Arneth, B; Härtter, S; Hiemke, C; Shams, M1
Bolton, JM; Leung, S; Metge, CJ; Sareen, J; Targownik, LE1
Cook, IA; Hunter, AM; Korb, AS; Leuchter, AF1
Bekers, O; Drent, M; Koek, GH; Kuijpers, PM; Limantoro, I; Wijnen, PA1
De Roover, A; Delbouille, MH; Delwaide, J; Detry, O; Hans, MF; Honoré, P; Monard, J1
Deuschle, M; Gilles, M; Hamann-Weber, B; Kopf, D; Lederbogen, F; Luppa, P; Paslakis, G1
Bortolatto, CF; Jesse, CR; Nogueira, CW; Wilhelm, EA1
Despiégel, N; François, C; Guelfucci, F; Saragoussi, D; Toumi, M; Wade, AG1
Caroselli, C; Ricci, G1
Kim, JH; Kim, JJ; Kim, S; Lee, H; Lee, JH; Min, BH; Rhee, JC; Rhee, PL; Son, HJ; Suh, YJ1
Christoph, M; Ebner, B; Ibrahim, K; Kolschmann, S; Schön, S; Stolte, D; Strasser, RH1
Fujiwara, M; Fujiwara, S; Ide, S; Ikeda, K; Ishihara, K; Minami, M; Sora, I; Uhl, GR1
Bérard, A; Ramos, É; St-André, M1
Krass, M; Vasar, E; Volke, V; Wegener, G1
Dhir, A; Kessar, SV; Kulkarni, SK; Malik, S; Singh, KN1
Berk, M; Liu, X; Wang, Y; Xiao, Z1
Iastrebov, DV1
Ding, ZB; Lu, L; Shi, HS; Wang, SJ; Wu, P; Zhu, WL1
Bobo, WV; Chen, H; Cook, IA; Fava, M; Husain, MM; Kornstein, SG; Kurian, BT; Lesser, IM; Luther, JF; Morris, DW; Nierenberg, AA; Rush, AJ; Shelton, RC; Stewart, JW; Trivedi, MH; Warden, D; Wisniewski, SR1
Du, G; Gao, X; Guo, X; Li, Z; Qin, X; Sun, H; Zhang, L; Zheng, X; Zhou, Y1
Cure, MC; Demirdas, A; Eren, I; Kirbas, A; Sutcu, R; Yilmaz, M; Yilmaz, N1
Bacq, A; Balasse, L; Biala, G; Chevarin, C; Gardier, AM; Gautron, S; Giros, B; Guiard, B; Hamon, M; Louis, F; Martres, MP; Schinkel, A; Vialou, V1
Abdel-Wahab, BA; Salama, RH1
Cuestas, E; Cuestas, ME1
Einarson, A1
Dai, MH; Han, Y; Li, DQ1
Barbui, C; Churchill, R; Cipriani, A; Furukawa, TA; Nakagawa, A; Omori, IM; Watanabe, N1
Horrillo, I; Martisova, E; Meana, JJ; Ortega, JE; Ramírez, MJ; Solas, M; Tordera, RM1
Amsterdam, J; Guerra, MW; Shults, J; Ten-Have, T1
Baker, RA; Bennetts, JS; Cardinal, T; Tully, PJ1
Karp, JF; Lotrich, F; Mazumdar, S; Morone, N; Morse, JQ; Reynolds, CF; Rollman, BL; Weiner, DK1
Liu, J; Qiao, W; Ren, L; Sun, Y; Wang, S; Yang, Y1
Badin, J; Bretaudeau Deguigne, M; Francino, MC; Perrotin, D; Turcant, A1
Cui, J; Du, GH; Gao, XX; Li, ZF; Li, ZY; Liu, XJ; Qin, XM; Sun, HF; Zhang, LZ; Zhou, YZ1
Chen, YC; Feng, SF; Shi, TY; Tan, QR; Wang, WN1
Archer, DF; Bao, W; Cheng, RJ; Constantine, G; Dupont, C; Pickar, JH; Racketa, J1
Delagrange, P; Elizalde, N; García-García, AL; Tordera, RM; Venzala, E1
Barbui, C; Churchill, R; Cipriani, A; Furukawa, TA; Imperadore, G; Purgato, M; Signoretti, A; Trespidi, C; Watanabe, N1
Liu, XH; Qin, J; Wang, Y; Wen, ZY; Yang, JL; Yu, JJ; Zhang, Y1
Fennell, J; Grocott, MP; Sevastru, S; Wakatsuki, M1
Campbell, JJ; George, M1
Shahani, L1
Barbui, C; Cipriani, A; Furukawa, TA; Koesters, M; Nosè, M; Omori, IM; Purgato, M; Trespidi, C1
Ghio, L; Presta, A; Puppo, S1
Blum, WF; Colla, M; Daseking, E; Deuschle, M; Gilles, M; Heuser, I; Kopf, D; Krumm, B; Lederbogen, F; Schilling, C; Weber-Hamann, B; Wudy, SA1
Li, L; Lin, M; Qian, MC; Shen, XH; Sun, JS; Yang, JH; Zhang, J; Zhong, H1
Gibson-Helm, M; Sayakhot, P; Teede, HJ; Vincent, A1
Feng, W; Fenli, S; Huande, L; Ronghua, Z1
Koerselman, GF; van Noorden, MS; Vergouwen, AC1
Jha, A; Tomar, R1
Crystal, S; Olfson, M; Sambamoorthi, U; Walkup, JT1
de Moor, RA; Egberts, AC; Mourad, L; ter Haar, J1
Fava, GA; Mangelli, L1
Blahak, C; Capelle, HH; Grips, E; Krauss, JK; Weigel, R; Wöhrle, JC1
Roxanas, MG1
Ak, I; Aksu, G; Sayar, K; Tosun, M1
Baudendistel, TE; Khurana, RN1
Alloui, A; Ardid, D; Constandil, L; Eschalier, A; Hernández, A; Laurido, C; Marchand, F; Pelissier, T; Soto-Moyano, R1
Bond, GR; Steele, PE; Uges, DR1
Chae, JH; Kim, JJ; Lee, C; Lee, CU; Lee, SJ; Pae, CU; Paik, IH1
Brandes, M; Cassano, P; Cohen, LS; Leblanc, GA; Lyster, A; Soares, CN1
Devanand, D; Fitzsimmons, L; Miyazaki, M; Roose, SP; Sackeim, H; Seidman, S; Turret, N1
Yanik, M1
de Guzman, MH; Goldberg, I; Ong, PY; Thiagalingam, S1
Ding, BK; Jin, KH; Ma, H; Qin, XS; Xie, SF1
Huande, L; Juan, H; Zhiling, Z1
Eloranta, A; Hallikainen, T; Repo-Tiihonen, E; Tiihonen, J1
Han, D; Wang, EC1
Fehér, LZ; Galsi, G; Hugyecz, M; Janka, Z; Juhász, A; Kálmán, J; Kovács, Z; Pákáski, M; Palotás, A; Puskás, LG; Rimanóczy, A; Szabó, Z1
Bexton, B; Han, D; Lelorier, J; Monfared, AA; Sheehy, O1
Efremidis, M; Evangelou, D; Kardaras, F; Korantzopoulos, P; Letsas, K; Pappas, L1
Czubak, A; Florek, E; Jodynis-Liebert, J; Kus, K; Nowakowska, E1
Cottraux, J1
Abozguia, K; Chudley, S; Gammage, M1
Cai, HL; Li, HD; Liu, W1
Altunbaşak, A; Celik, O; Demirdaş, A; Eren, I; Naziroğlu, M; Ozmen, I; Uğuz, AC; Uz, E1
Allgulander, C; Sheehan, DV1
Ahmed, S; Dunlop, BW; Dunner, DL; Ferguson, JM; Friedman, ES; Gelenberg, AJ; Hirschfeld, RM; Keller, MB; Kocsis, JH; Kornstein, SG; Nemeroff, CB; Ninan, PT; Pedersen, R; Rothschild, AJ; Schatzberg, AF; Schmidt, M; Shelton, RC; Thase, ME; Trivedi, MH; Yan, B; Zajecka, JM1
Aviv, A; Barak, Y; Mazeh, D; Shahal, B; Zemishlani, H1
Altindag, A; Gunes, M1
Jürgens, TP; Koch, HJ; Leinisch, E1
Jiang, Q; Lenox-Smith, AJ1
Aparicio, N; De Boer, WA; Jansen, JB; Laheij, RJ; Tan, AC; Van den Hazel, S; van Kerkhoven, LA; Witteman, BJ1
Derivan, A; Entsuah, AR; Kikta, D1
Benfield, P; Holliday, SM1
Ellingrod, VL; Perry, PJ1
Baumel, B; Ferguson, J; Khan, A; Rudolph, R; Ryan, P; Shrivastava, R1
Dierick, M1
Entsuah, R1
Blanchard, C; Bourin, M; Danjou, P; Hackett, D; Lecrubier, Y; Moon, CA; Schifano, F1
Karki, SD; Masood, GR; Patterson, WR1
Ansseau, M1
Boyd, IW1
Béïque, JC; Blier, P; de Montigny, C; Debonnel, G1
Dahmen, N; Hopf, HC; Marx, J; Röder, R; Tettenborn, B1
Elizur, A; Mazeh, D; Melamed, Y1
Schwartz, TL1
Brown, ES; Hong, SC1
Samuel, RZ1
Gregson, J1
Gunning, K; Magill, MK1
Cook, IA; Leuchter, AF1
Brown, WA; Khan, A; Khan, SR; Leventhal, RM1
Boskailo, E; Djuric-Bijedic, Z; Lewis, J; Pavkovic, I; Smajkic, A; Weine, S1
Morrow, TJ1
Dunn, AJ; Swiergiel, AH1
Ismail, M; Lyster, G1
Höfler, M; Hoyer, J; Krause, P; Wittchen, HU1
Pallay, AG; Pedersen, RD; Rudolph, RL1
Finnerty, R; Goldberg, HL1

Reviews

17 review(s) available for cyclohexanol and Depression

ArticleYear
Desvenlafaxine in the treatment of major depression: an updated overview.
    Expert opinion on pharmacotherapy, 2021, Volume: 22, Issue:9

    Topics: Adolescent; Adult; Antidepressive Agents; Child; Cyclohexanols; Depression; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Drug Interactions; Female; Humans

2021
Treatment response for acute depression is not associated with number of previous episodes: lack of evidence for a clinical staging model for major depressive disorder.
    Journal of affective disorders, 2013, Sep-05, Volume: 150, Issue:2

    Topics: Acute Disease; Adult; Antidepressive Agents; Citalopram; Cyclohexanols; Depression; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Paroxetine; Recurrence; Thiophenes; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride

2013
PharmGKB summary: venlafaxine pathway.
    Pharmacogenetics and genomics, 2014, Volume: 24, Issue:1

    Topics: Animals; Aryl Hydrocarbon Hydroxylases; Cyclohexanols; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Depression; Genetic Variation; Genotype; Humans; Metabolic Networks and Pathways; Mice; Pharmacogenetics; Selective Serotonin Reuptake Inhibitors; Substrate Specificity; Venlafaxine Hydrochloride

2014
Which placebo to cure depression? A thought-provoking network meta-analysis.
    BMC medicine, 2013, Oct-25, Volume: 11

    Topics: Antidepressive Agents; Biomedical Research; Clinical Trials as Topic; Cyclohexanols; Depression; Fluoxetine; Humans; Placebos; Treatment Outcome; Venlafaxine Hydrochloride

2013
Is there a correlation between venlafaxine therapy during pregnancy and a higher incidence of necrotizing enterocolitis?
    World journal of pediatrics : WJP, 2009, Volume: 5, Issue:1

    Topics: Colectomy; Colon; Cyclohexanols; Depression; Enterocolitis, Necrotizing; Female; Humans; Ileum; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors; Twins; Venlafaxine Hydrochloride

2009
Mirtazapine versus other antidepressive agents for depression.
    The Cochrane database of systematic reviews, 2011, Dec-07, Issue:12

    Topics: Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depression; Humans; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride

2011
Citalopram versus other anti-depressive agents for depression.
    The Cochrane database of systematic reviews, 2012, Jul-11, Issue:7

    Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depression; Humans; Morpholines; Paroxetine; Reboxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride

2012
Duloxetine versus other anti-depressive agents for depression.
    The Cochrane database of systematic reviews, 2012, Oct-17, Volume: 10

    Topics: Antidepressive Agents; Citalopram; Cyclohexanols; Depression; Desvenlafaxine Succinate; Dibenzothiazepines; Duloxetine Hydrochloride; Fluoxetine; Humans; Paroxetine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Thiophenes; Venlafaxine Hydrochloride

2012
New formulations of existing antidepressants: advantages in the management of depression.
    CNS drugs, 2004, Volume: 18, Issue:8

    Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Chemistry, Pharmaceutical; Cyclohexanols; Delayed-Action Preparations; Depression; Drug Evaluation; Fluoxetine; Humans; Mianserin; Mirtazapine; Molecular Conformation; Venlafaxine Hydrochloride

2004
Remission from depression : a review of venlafaxine clinical and economic evidence.
    PharmacoEconomics, 2005, Volume: 23, Issue:6

    Topics: Antidepressive Agents, Second-Generation; Cost of Illness; Cyclohexanols; Depression; Humans; Remission Induction; Secondary Prevention; Venlafaxine Hydrochloride

2005
[Psychotherapies: what is the impact on the cortical and subcortical levels?].
    L'Encephale, 2006, Volume: 32, Issue:Pt 2

    Topics: Brain; Cyclohexanols; Depression; Humans; Obsessive-Compulsive Disorder; Phobic Disorders; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride

2006
Generalized anxiety disorder: raising the expectations of treatment.
    Psychopharmacology bulletin, 2002,Summer, Volume: 36 Suppl 2

    Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Cyclohexanols; Depression; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride

2002
[A clinical challenge. Pragmatic treatment of migraine and concomitant depression].
    Schmerz (Berlin, Germany), 2008, Volume: 22 Suppl 1

    Topics: Amitriptyline; Analgesics, Non-Narcotic; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antiemetics; Arrhythmias, Cardiac; Cross-Over Studies; Cyclohexanols; Depression; Drug Interactions; Drug Therapy, Combination; Electrocardiography; Fluoxetine; Humans; Migraine Disorders; Polypharmacy; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Time Factors; Venlafaxine Hydrochloride

2008
Venlafaxine. A review of its pharmacology and therapeutic potential in depression.
    Drugs, 1995, Volume: 49, Issue:2

    Topics: Animals; Antidepressive Agents, Second-Generation; Cardiovascular System; Central Nervous System; Cyclohexanols; Depression; Dosage Forms; Dose-Response Relationship, Drug; Drug Interactions; Humans; Synaptic Transmission; Venlafaxine Hydrochloride

1995
Venlafaxine: a heterocyclic antidepressant.
    American journal of hospital pharmacy, 1994, Dec-15, Volume: 51, Issue:24

    Topics: Antidepressive Agents, Second-Generation; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclohexanols; Depression; Drug Interactions; Humans; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride

1994
Etrank: a ranking procedure for handling missing data in clinical trials: application to venlafaxine extended-release depression clinical trial.
    Journal of biopharmaceutical statistics, 1996, Volume: 6, Issue:4

    Topics: Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cyclohexanols; Data Interpretation, Statistical; Depression; Humans; Longitudinal Studies; Mathematical Computing; Software; Statistics as Topic; Venlafaxine Hydrochloride

1996
The pharmacoeconomics of venlafaxine in depression.
    The American journal of managed care, 2001, Volume: 7, Issue:11 Suppl

    Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety; Cost-Benefit Analysis; Cyclohexanols; Depression; Drug Utilization Review; Humans; Managed Care Programs; Selective Serotonin Reuptake Inhibitors; United States; Venlafaxine Hydrochloride

2001

Trials

34 trial(s) available for cyclohexanol and Depression

ArticleYear
Clustering patients by depression symptoms to predict venlafaxine ER antidepressant efficacy: Individual patient data analysis.
    Journal of psychiatric research, 2020, Volume: 129

    Topics: Antidepressive Agents; Cluster Analysis; Cyclohexanols; Data Analysis; Depression; Depressive Disorder, Major; Double-Blind Method; Humans; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride

2020
Cytochrome P450 2D6 phenoconversion is common in patients being treated for depression: implications for personalized medicine.
    The Journal of clinical psychiatry, 2013, Volume: 74, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Cytochrome P-450 CYP2D6; Delayed-Action Preparations; Depression; Female; Humans; Male; Middle Aged; Phenotype; Precision Medicine; Venlafaxine Hydrochloride

2013
Increase in work productivity of depressed individuals with improvement in depressive symptom severity.
    The American journal of psychiatry, 2013, Volume: 170, Issue:6

    Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depression; Drug Therapy, Combination; Efficiency; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride; Work; Young Adult

2013
BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.
    Progress in neuro-psychopharmacology & biological psychiatry, 2014, Jan-03, Volume: 48

    Topics: Adult; Aged; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Cyclohexanols; Depression; Desvenlafaxine Succinate; Double-Blind Method; Female; Humans; Hydrocortisone; Interleukin-6; Male; Middle Aged; Outpatients; Psychiatric Status Rating Scales; Saliva; Severity of Illness Index; Statistics as Topic; Young Adult

2014
Efficacy of repetitive transcranial magnetic stimulation in the prevention of relapse of depression: study protocol for a randomized controlled trial.
    Trials, 2013, Oct-17, Volume: 14

    Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; China; Clinical Protocols; Combined Modality Therapy; Cyclohexanols; Depression; Humans; Middle Aged; Psychiatric Status Rating Scales; Research Design; Secondary Prevention; Severity of Illness Index; Single-Blind Method; Time Factors; Transcranial Magnetic Stimulation; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult

2013
Increased prefrontal cortex activity during negative emotion regulation as a predictor of depression symptom severity trajectory over 6 months.
    JAMA psychiatry, 2013, Volume: 70, Issue:11

    Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depression; Depressive Disorder, Major; Double-Blind Method; Emotions; Fluoxetine; Functional Neuroimaging; Humans; Prefrontal Cortex; Venlafaxine Hydrochloride

2013
Screening for neuropathic pain after spinal cord injury with the spinal cord injury pain instrument (SCIPI): a preliminary validation study.
    Spinal cord, 2014, Volume: 52, Issue:5

    Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cross-Sectional Studies; Cyclohexanols; Depression; Female; Humans; Male; Middle Aged; Neuralgia; Pain Measurement; Principal Component Analysis; Psychometrics; Reproducibility of Results; ROC Curve; Self Report; Spinal Cord Injuries; Surveys and Questionnaires; United States; Venlafaxine Hydrochloride; Young Adult

2014
Improvements in quality of life with desvenlafaxine 50mg/d vs placebo in employed adults with major depressive disorder.
    Journal of affective disorders, 2014, Volume: 166

    Topics: Adult; Aged; Antidepressive Agents; Cyclohexanols; Depression; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Employment; Female; Humans; Male; Middle Aged; Placebos; Quality of Life; Surveys and Questionnaires; Young Adult

2014
Treating concurrent chronic low back pain and depression with low-dose venlafaxine: an initial identification of "easy-to-use" clinical predictors of early response.
    Pain medicine (Malden, Mass.), 2014, Volume: 15, Issue:7

    Topics: Aged; Antidepressive Agents, Second-Generation; Chronic Pain; Cyclohexanols; Depression; Female; Humans; Low Back Pain; Male; Treatment Outcome; Venlafaxine Hydrochloride

2014
Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression.
    Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 2009, Volume: 120, Issue:7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Biomarkers; Brain Mapping; Cerebral Cortex; Cyclohexanols; Depression; Double-Blind Method; Electroencephalography; Female; Fluoxetine; Gyrus Cinguli; Humans; Male; Middle Aged; Theta Rhythm; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult

2009
Venlafaxine and mirtazapine treatment lowers serum concentrations of dehydroepiandrosterone-sulfate in depressed patients remitting during the course of treatment.
    Journal of psychiatric research, 2010, Volume: 44, Issue:8

    Topics: Adult; Age Factors; Aged; Analysis of Variance; Antidepressive Agents; Case-Control Studies; Cyclohexanols; Dehydroepiandrosterone Sulfate; Depression; Female; Humans; Hydrocortisone; Male; Mianserin; Middle Aged; Mirtazapine; Saliva; Secondary Prevention; Sex Factors; Venlafaxine Hydrochloride

2010
Efficacy of venlafaxine for symptomatic relief in young adult patients with functional chest pain: a randomized, double-blind, placebo-controlled, crossover trial.
    The American journal of gastroenterology, 2010, Volume: 105, Issue:7

    Topics: Adult; Anxiety; Chest Pain; Chi-Square Distribution; Cross-Over Studies; Cyclohexanols; Delayed-Action Preparations; Depression; Double-Blind Method; Esophageal Diseases; Esophageal pH Monitoring; Female; Humans; Male; Manometry; Placebos; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Statistics, Nonparametric; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride

2010
[Treatment-resistant depressions in borderline psychiatry].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2011, Volume: 111, Issue:4

    Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Drug Administration Schedule; Drug Resistance; Female; Humans; Male; Middle Aged; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult

2011
Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report.
    Journal of affective disorders, 2011, Volume: 133, Issue:3

    Topics: Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Cyclohexanols; Depression; Depressive Disorder; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Outpatients; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride

2011
Addressing both depression and pain in late life: the methodology of the ADAPT study.
    Pain medicine (Malden, Mass.), 2012, Volume: 13, Issue:3

    Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Behavior Therapy; Comorbidity; Cyclohexanols; Depression; Female; Humans; Low Back Pain; Male; Middle Aged; Problem Solving; Research Design; Venlafaxine Hydrochloride

2012
Effect of desvenlafaxine on mood and climacteric symptoms in menopausal women with moderate to severe vasomotor symptoms.
    Climacteric : the journal of the International Menopause Society, 2013, Volume: 16, Issue:1

    Topics: Adult; Affective Symptoms; Aged; Anger; Anxiety; Back Pain; Confusion; Cyclohexanols; Depression; Desvenlafaxine Succinate; Double-Blind Method; Fatigue; Female; Hot Flashes; Humans; Hyperhidrosis; Irritable Mood; Menopause; Middle Aged; Neurotransmitter Uptake Inhibitors; Patient Satisfaction; Sexual Behavior; Surveys and Questionnaires

2013
Leptin plasma concentrations increase during antidepressant treatment with amitriptyline and mirtazapine, but not paroxetine and venlafaxine: leptin resistance mediated by antihistaminergic activity?
    Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Amitriptyline; Analysis of Variance; Antidepressive Agents; Biomarkers; Body Mass Index; Cyclohexanols; Depression; Female; Humans; Leptin; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Time Factors; Treatment Outcome; Up-Regulation; Venlafaxine Hydrochloride; Weight Gain; Young Adult

2013
[Effects of apolipoprotein E genetic polymorphism on susceptibility of depression and efficacy of antidepressants].
    Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 2012, Volume: 34, Issue:6

    Topics: Adolescent; Adult; Aged; Antidepressive Agents; Apolipoproteins E; Cyclohexanols; Depression; Female; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Paroxetine; Polymorphism, Genetic; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult

2012
Venlafaxine treatment of fibromyalgia.
    The Annals of pharmacotherapy, 2003, Volume: 37, Issue:11

    Topics: Adrenergic Uptake Inhibitors; Adult; Anxiety; Cyclohexanols; Depression; Female; Fibromyalgia; Humans; Pain; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride

2003
Efficacy and tolerability of premenstrual use of venlafaxine (flexible dose) in the treatment of premenstrual dysphoric disorder.
    Journal of clinical psychopharmacology, 2004, Volume: 24, Issue:5

    Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Luteal Phase; Premenstrual Syndrome; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride

2004
An open trial of venlafaxine for the treatment of late-life atypical depression.
    International journal of geriatric psychiatry, 2004, Volume: 19, Issue:10

    Topics: Age of Onset; Aged; Antidepressive Agents; Chi-Square Distribution; Cyclohexanols; Depression; Female; Humans; Male; Middle Aged; Venlafaxine Hydrochloride

2004
Effects of venlafaxine treatment on clozapine plasma levels in schizophrenic patients.
    Neuropsychobiology, 2005, Volume: 51, Issue:4

    Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Chromatography, High Pressure Liquid; Clozapine; Cyclohexanols; Depression; Humans; Male; Middle Aged; Schizophrenia; Venlafaxine Hydrochloride

2005
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases.
    Biological psychiatry, 2007, Dec-15, Volume: 62, Issue:12

    Topics: Adolescent; Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Middle Aged; Retrospective Studies; Secondary Prevention; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride

2007
A randomized, single-blind, comparison of venlafaxine with paroxetine in elderly patients suffering from resistant depression.
    International clinical psychopharmacology, 2007, Volume: 22, Issue:6

    Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Diagnostic and Statistical Manual of Mental Disorders; Dizziness; Dose-Response Relationship, Drug; Drug Resistance; Female; Humans; Male; Nausea; Paroxetine; Psychiatric Status Rating Scales; Remission Induction; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Xerostomia

2007
Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    International clinical psychopharmacology, 2008, Volume: 23, Issue:3

    Topics: Adult; Antidepressive Agents, Second-Generation; Australia; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depression; Double-Blind Method; Drug Administration Schedule; Drug Resistance; Europe; Female; Humans; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Failure; Venlafaxine Hydrochloride

2008
Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2008, Volume: 6, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Anxiety; Cyclohexanols; Depression; Double-Blind Method; Dyspepsia; Female; Humans; Male; Middle Aged; Placebos; Quality of Life; Venlafaxine Hydrochloride

2008
Venlafaxine: measuring the onset of antidepressant action.
    Psychopharmacology bulletin, 1995, Volume: 31, Issue:2

    Topics: Antidepressive Agents; Cyclohexanols; Depression; Follow-Up Studies; Humans; Placebo Effect; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride

1995
Venlafaxine in depressed geriatric outpatients: an open-label clinical study.
    Psychopharmacology bulletin, 1995, Volume: 31, Issue:4

    Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Female; Humans; Male; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride

1995
An open-label evaluation of the long-term safety of oral venlafaxine in depressed elderly patients.
    Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 1996, Volume: 8, Issue:3

    Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Blood Pressure; Cyclohexanols; Depression; Electrocardiography; Female; Humans; Male; Sampling Studies; Severity of Illness Index; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride

1996
Efficacy of venlafaxine in depressive illness in general practice.
    Acta psychiatrica Scandinavica, 1997, Volume: 95, Issue:6

    Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety; Cyclohexanols; Depression; Double-Blind Method; Family Practice; Female; Humans; Imipramine; Male; Middle Aged; Placebo Effect; Prospective Studies; Social Adjustment; Treatment Outcome; Venlafaxine Hydrochloride

1997
Therapy of early poststroke depression with venlafaxine: safety, tolerability, and efficacy as determined in an open, uncontrolled clinical trial.
    Stroke, 1999, Volume: 30, Issue:3

    Topics: Aged; Antidepressive Agents, Second-Generation; Cerebrovascular Disorders; Cyclohexanols; Depression; Female; Humans; Male; Venlafaxine Hydrochloride

1999
Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: a replication analysis of the Food and Drug Administration Database.
    The international journal of neuropsychopharmacology, 2001, Volume: 4, Issue:2

    Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Databases, Factual; Depression; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Risk; Selective Serotonin Reuptake Inhibitors; Suicide; Suicide Prevention; Suicide, Attempted; United States; United States Food and Drug Administration; Venlafaxine Hydrochloride

2001
Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms.
    Journal of traumatic stress, 2001, Volume: 14, Issue:3

    Topics: Adult; Cyclohexanols; Depression; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Refugees; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride

2001
Can improvement in well-being and functioning be distinguished from depression improvement in antidepressant clinical trials?
    Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2002, Volume: 11, Issue:1

    Topics: Activities of Daily Living; Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Controlled Clinical Trials as Topic; Cyclohexanols; Depression; Factor Analysis, Statistical; Female; Humans; Imipramine; Male; Outcome Assessment, Health Care; Psychiatric Status Rating Scales; Psychometrics; Reproducibility of Results; Venlafaxine Hydrochloride

2002

Other Studies

115 other study(ies) available for cyclohexanol and Depression

ArticleYear
What next? A Bayesian hierarchical modeling re-examination of treatments for adolescents with selective serotonin reuptake inhibitor-resistant depression.
    Depression and anxiety, 2020, Volume: 37, Issue:9

    Topics: Adolescent; Bayes Theorem; Cyclohexanols; Depression; Depressive Disorder, Major; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Treatment Outcome

2020
Psychomotor depressive symptoms may differentially respond to venlafaxine.
    International clinical psychopharmacology, 2013, Volume: 28, Issue:3

    Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Prospective Studies; Psychomotor Agitation; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride

2013
Levomilnacipran (F2695), a norepinephrine-preferring SNRI: profile in vitro and in models of depression and anxiety.
    Neuropharmacology, 2013, Volume: 70

    Topics: Adrenergic Uptake Inhibitors; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Behavior, Animal; Cerebral Cortex; Cyclohexanols; Cyclopropanes; Depression; Dopamine; Duloxetine Hydrochloride; Humans; Male; Mice; Milnacipran; Motor Activity; Neurotransmitter Transport Proteins; Norepinephrine; Rats; Serotonin; Synaptosomes; Thiophenes; Venlafaxine Hydrochloride

2013
Further evaluation of the neuropharmacological determinants of the antidepressant-like effects of curcumin.
    CNS & neurological disorders drug targets, 2013, Volume: 12, Issue:4

    Topics: Animals; Antidepressive Agents; Brain; Curcumin; Cyclohexanols; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Immunosuppressive Agents; Male; Mice; Mice, Knockout; Monoamine Oxidase Inhibitors; Protein Binding; Receptor, Cannabinoid, CB1; Receptors, Biogenic Amine; Swimming

2013
Augmentation therapy with alpha-lipoic acid and desvenlafaxine: a future target for treatment of depression?
    Naunyn-Schmiedeberg's archives of pharmacology, 2013, Volume: 386, Issue:8

    Topics: Animals; Antidepressive Agents; Antioxidants; Behavior, Animal; Corticosterone; Cyclohexanols; Depression; Desvenlafaxine Succinate; Drug Therapy, Combination; Exploratory Behavior; Female; Hindlimb Suspension; Mice; Stress, Psychological; Swimming; Thioctic Acid

2013
The combined treatment of venlafaxine and quetiapine for treatment-resistant depression: a clinical study.
    The Journal of neuropsychiatry and clinical neurosciences, 2013,Spring, Volume: 25, Issue:2

    Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Cohort Studies; Cyclohexanols; Depression; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Quetiapine Fumarate; Treatment Outcome; Venlafaxine Hydrochloride

2013
Beneficial effects of fluoxetine, reboxetine, venlafaxine, and voluntary running exercise in stressed male rats with anxiety- and depression-like behaviors.
    Behavioural brain research, 2013, Aug-01, Volume: 250

    Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Cyclohexanols; Depression; Disease Models, Animal; Fluoxetine; Food Preferences; Male; Maze Learning; Morpholines; Physical Conditioning, Animal; Rats; Rats, Wistar; Reboxetine; Restraint, Physical; Running; Stress, Psychological; Sucrose; Swimming; Venlafaxine Hydrochloride

2013
Changes in the utilization of venlafaxine after the introduction of generics in Sweden.
    Applied health economics and health policy, 2013, Volume: 11, Issue:4

    Topics: Antidepressive Agents, Second-Generation; Confidence Intervals; Cyclohexanols; Depression; Drug Prescriptions; Drugs, Generic; Humans; Sweden; Venlafaxine Hydrochloride

2013
Prenatal antidepressant exposure and risk of spontaneous abortion - a population-based study.
    PloS one, 2013, Volume: 8, Issue:8

    Topics: Abortion, Spontaneous; Adult; Antidepressive Agents; Cyclohexanols; Depression; Duloxetine Hydrochloride; Female; Humans; Maternal-Fetal Exchange; Mianserin; Mirtazapine; Pregnancy; Risk; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride; Young Adult

2013
[Antidepressant treatment associated hyponatremia -- case report].
    Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2013, Volume: 15, Issue:3

    Topics: Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Critical Care; Cyclohexanols; Depression; Depressive Disorder, Major; Drug Administration Schedule; Drug Therapy, Combination; Humans; Hyponatremia; Male; Mianserin; Mirtazapine; Recurrence; Severity of Illness Index; Sodium; Suicide, Attempted; Treatment Outcome; Venlafaxine Hydrochloride

2013
When depression doesn't lead with depression.
    JAMA psychiatry, 2013, Volume: 70, Issue:11

    Topics: Anger; Bipolar Disorder; Cyclohexanols; Depression; Depressive Disorder, Major; Emotions; Female; Fluoxetine; Humans; Irritable Mood; Male; Mood Disorders; Prefrontal Cortex; Venlafaxine Hydrochloride

2013
Phenoconversion of cytochrome P450 2D6: the need for identifying the intermediate metabolizer genotype.
    The Journal of clinical psychiatry, 2013, Volume: 74, Issue:10

    Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Cytochrome P-450 CYP2D6; Depression; Female; Humans; Male; Precision Medicine

2013
Dr Preskorn replies.
    The Journal of clinical psychiatry, 2013, Volume: 74, Issue:10

    Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Cytochrome P-450 CYP2D6; Depression; Female; Humans; Male; Precision Medicine

2013
Development and evaluation of brain targeted intranasal alginate nanoparticles for treatment of depression.
    Journal of psychiatric research, 2014, Volume: 48, Issue:1

    Topics: Administration, Intranasal; Alginates; Animals; Antidepressive Agents; Brain; Cyclohexanols; Depression; Disease Models, Animal; Female; Glucuronic Acid; Hexuronic Acids; Male; Motor Activity; Nanoparticles; Nasal Mucosa; Pharmacokinetics; Rats; Rats, Wistar; Swimming; Time Factors; Venlafaxine Hydrochloride

2014
Interaction of valproic acid and the antidepressant drugs doxepin and venlafaxine: analysis of therapeutic drug monitoring data under naturalistic conditions.
    International clinical psychopharmacology, 2014, Volume: 29, Issue:4

    Topics: Adult; Aged; Antidepressive Agents; Biotransformation; Cyclohexanols; Depression; Dose-Response Relationship, Drug; Doxepin; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; GABA Agents; Germany; Histamine Antagonists; Hospitals, University; Humans; Male; Middle Aged; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Valproic Acid; Venlafaxine Hydrochloride

2014
Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease.
    Parkinsonism & related disorders, 2014, Volume: 20, Issue:6

    Topics: Aged; Antidepressive Agents; Anxiety; Cyclohexanols; Datasets as Topic; Depression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease; Paroxetine; Predictive Value of Tests; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Severity of Illness Index; Venlafaxine Hydrochloride

2014
Desvenlafaxine prevents white matter injury and improves the decreased phosphorylation of the rate-limiting enzyme of cholesterol synthesis in a chronic mouse model of depression.
    Journal of neurochemistry, 2014, Volume: 131, Issue:2

    Topics: Animals; Antidepressive Agents; Cholesterol; Cyclohexanols; Depression; Desvenlafaxine Succinate; Disease Models, Animal; Female; Mice; Mice, Inbred C57BL; Phosphorylation; Random Allocation; White Matter

2014
Venlafaxine inhibits apoptosis of hippocampal neurons by up-regulating brain-derived neurotrophic factor in a rat depression model.
    International journal of clinical and experimental pathology, 2014, Volume: 7, Issue:8

    Topics: Animals; Antidepressive Agents, Second-Generation; Apoptosis; Behavior, Animal; Blotting, Western; Brain-Derived Neurotrophic Factor; Cyclohexanols; Depression; Disease Models, Animal; Hippocampus; Immunohistochemistry; In Situ Nick-End Labeling; Male; Microscopy, Electron, Transmission; Neurons; Rats; Rats, Sprague-Dawley; Up-Regulation; Venlafaxine Hydrochloride

2014
In vitro and in vivo characterization of PA01, a novel promising triple reuptake inhibitor.
    Physiology & behavior, 2015, Volume: 138

    Topics: Animals; Antidepressive Agents; Binding, Competitive; CHO Cells; Cricetulus; Cyclohexanols; Depression; Desvenlafaxine Succinate; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Humans; Hypothermia; Male; Mice; Molecular Structure; Motor Activity; Neurotransmitter Uptake Inhibitors; Norepinephrine; Rats, Sprague-Dawley; Serotonin; Species Specificity

2015
Differential co-expression and regulation analyses reveal different mechanisms underlying major depressive disorder and subsyndromal symptomatic depression.
    BMC bioinformatics, 2015, Apr-03, Volume: 16

    Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Biomarkers; Case-Control Studies; Cyclohexanols; Depression; Depressive Disorder, Major; Female; Gene Regulatory Networks; Humans; Leukocytes, Mononuclear; Male; Microarray Analysis; Venlafaxine Hydrochloride

2015
[Venlafaxine in the treatment of moderate and severe depressions: the ways to increase treatment efficacy].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2015, Volume: 115, Issue:1

    Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult

2015
Venlafaxine inhibits apoptosis of hippocampal neurons by up-regulating brain-derived neurotrophic factor in a rat depression model.
    Die Pharmazie, 2014, Volume: 69, Issue:12

    Topics: Animals; Apoptosis; Behavior, Animal; Brain-Derived Neurotrophic Factor; Cyclohexanols; Depression; Hippocampus; Male; Neurons; Nitric Oxide; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Signal Transduction; Up-Regulation; Venlafaxine Hydrochloride; Weight Gain

2014
Antidepressant-like Effects of LPM580153, A Novel Potent Triple Reuptake Inhibitor.
    Scientific reports, 2016, Apr-07, Volume: 6

    Topics: Anhedonia; Animals; Antidepressive Agents; Biological Transport; Blotting, Western; Brain-Derived Neurotrophic Factor; Cell Line, Tumor; Cell Survival; Corticosterone; Cyclohexanols; Depression; Disease Models, Animal; Dopamine; Extracellular Signal-Regulated MAP Kinases; Humans; Male; Mice; Molecular Structure; Neuroblastoma; Neurotransmitter Uptake Inhibitors; Norepinephrine; Phenethylamines; Rats, Sprague-Dawley; Serotonin; Weight Gain

2016
Selective solid-phase extraction using molecularly imprinted polymers for analysis of venlafaxine, O-desmethylvenlafaxine, and N-desmethylvenlafaxine in plasma samples by liquid chromatography-tandem mass spectrometry.
    Journal of chromatography. A, 2016, Aug-05, Volume: 1458

    Topics: Acrylates; Antidepressive Agents; Chromatography, High Pressure Liquid; Cyclohexanols; Depression; Desvenlafaxine Succinate; Humans; Methacrylates; Microscopy, Electron, Scanning; Molecular Imprinting; Nitriles; Polymerization; Polymers; Solid Phase Extraction; Spectroscopy, Fourier Transform Infrared; Tandem Mass Spectrometry; Toluene; Venlafaxine Hydrochloride

2016
Do new-generation antidepressants work?
    Irish medical journal, 2008, Volume: 101, Issue:5

    Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Fluoxetine; Humans; Paroxetine; Piperazines; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride

2008
Risperidone, an atypical antipsychotic enhances the antidepressant-like effect of venlafaxine or fluoxetine: possible involvement of alpha-2 adrenergic receptors.
    Neuroscience letters, 2008, Nov-07, Volume: 445, Issue:1

    Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Cyclohexanols; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Immobility Response, Tonic; Locomotion; Male; Mice; Receptors, Adrenergic, alpha-2; Risperidone; Swimming; Venlafaxine Hydrochloride; Yohimbine

2008
Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009, Volume: 34, Issue:6

    Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Brain; Cyclohexanols; Depression; Down-Regulation; Fenclonine; Male; Monoamine Oxidase Inhibitors; Morpholines; Norepinephrine Plasma Membrane Transport Proteins; Phenelzine; Protein Synthesis Inhibitors; Protriptyline; Rats; Rats, Sprague-Dawley; Reboxetine; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Sertraline; Venlafaxine Hydrochloride

2009
Drug approvals: '08 in review. Desvenlafaxine (Pristiq).
    The Nurse practitioner, 2009, Volume: 34, Issue:2

    Topics: Cyclohexanols; Depression; Desvenlafaxine Succinate; Humans; Neurotransmitter Uptake Inhibitors

2009
Altered CB receptor-signaling in prefrontal cortex from an animal model of depression is reversed by chronic fluoxetine.
    Journal of neurochemistry, 2009, Volume: 108, Issue:6

    Topics: Animals; Antidepressive Agents, Second-Generation; Autoradiography; Cyclohexanols; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Drug Administration Schedule; Exploratory Behavior; Fluoxetine; Guanosine 5'-O-(3-Thiotriphosphate); Immunosuppressive Agents; Isotopes; Male; Olfactory Bulb; Prefrontal Cortex; Protein Binding; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Signal Transduction; Time Factors

2009
Experience of the use of velaxin (venlafaxine) in anxious depression.
    Neuroscience and behavioral physiology, 2009, Volume: 39, Issue:3

    Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depression; Female; Humans; Inpatients; Male; Middle Aged; Outpatients; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride

2009
Regional origin and decrease of pain in patients with depressive symptoms under treatment with venlafaxine.
    Social psychiatry and psychiatric epidemiology, 2010, Volume: 45, Issue:1

    Topics: Acculturation; Adult; Analgesics; Antidepressive Agents, Second-Generation; Chronic Disease; Comorbidity; Culture; Cyclohexanols; Depression; Ethnicity; Europe; Europe, Eastern; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Physicians, Family; Psychophysiologic Disorders; Severity of Illness Index; Switzerland; Treatment Outcome; Venlafaxine Hydrochloride

2010
Rapid and reliable genotyping procedure for detection of alleles with mutations, deletion, or/and duplication of the CYP2D6 gene.
    Clinical biochemistry, 2009, Volume: 42, Issue:12

    Topics: Adult; Alleles; Antidepressive Agents, Second-Generation; Base Sequence; Cyclohexanols; Cytochrome P-450 CYP2D6; Depression; DNA Mutational Analysis; Female; Gene Duplication; Genotype; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Reproducibility of Results; Sensitivity and Specificity; Sequence Analysis, DNA; Sequence Deletion; Venlafaxine Hydrochloride

2009
Selective serotonin reuptake inhibitors are associated with a modest increase in the risk of upper gastrointestinal bleeding.
    The American journal of gastroenterology, 2009, Volume: 104, Issue:6

    Topics: Aged; Analgesics; Cyclohexanols; Depression; Dose-Response Relationship, Drug; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Incidence; Male; Manitoba; Retrospective Studies; Risk Assessment; Risk Factors; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride

2009
Depressive effect of an antidepressant: therapeutic failure of venlafaxine in a case lacking CYP2D6 activity.
    Annals of clinical biochemistry, 2009, Volume: 46, Issue:Pt 6

    Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Cytochrome P-450 CYP2D6; Depression; Female; Humans; Middle Aged; Models, Chemical; Polymorphism, Genetic; Risk; Venlafaxine Hydrochloride

2009
Fulminant hepatic failure induced by venlafaxine and trazodone therapy: a case report.
    Transplantation proceedings, 2009, Volume: 41, Issue:8

    Topics: Aspartate Aminotransferases; Bilirubin; Cyclohexanols; Depression; Factor V; Female; Humans; International Normalized Ratio; Jaundice; Liver Failure, Acute; Liver Transplantation; Middle Aged; Selective Serotonin Reuptake Inhibitors; Trazodone; Treatment Outcome; Venlafaxine Hydrochloride

2009
Desvenlafaxine: application withdrawal. Desvenlafaxine: withdrawal of marketing application for depression also.
    Prescrire international, 2009, Volume: 18, Issue:103

    Topics: Antidepressive Agents; Cyclohexanols; Depression; Depressive Disorder; Desvenlafaxine Succinate; Europe; Hot Flashes; Humans; Investigational New Drug Application; Marketing of Health Services; Neurotransmitter Uptake Inhibitors; Postmenopause; United States

2009
Agomelatine: new drug. Adverse effects and no proven efficacy.
    Prescrire international, 2009, Volume: 18, Issue:104

    Topics: Acetamides; Animals; Antidepressive Agents; Bias; Carcinogens; Clinical Trials as Topic; Cyclohexanols; Depression; Depressive Disorder; Double-Blind Method; Drug Approval; Europe; Fluoxetine; Humans; Hypnotics and Sedatives; Melatonin; Paroxetine; Psychiatric Status Rating Scales; Receptors, Melatonin; Recurrence; Selective Serotonin Reuptake Inhibitors; Suicide; Treatment Outcome; Venlafaxine Hydrochloride

2009
Involvement of potassium channels in the antidepressant-like effect of venlafaxine in mice.
    Life sciences, 2010, Feb-27, Volume: 86, Issue:9-10

    Topics: Animals; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Male; Mice; Motor Activity; Potassium Channel Blockers; Potassium Channels; Venlafaxine Hydrochloride

2010
Healthcare expenditure in severely depressed patients treated with escitalopram, generic SSRIs or venlafaxine in the UK.
    Current medical research and opinion, 2010, Volume: 26, Issue:5

    Topics: Adolescent; Adult; Aged; Citalopram; Cyclohexanols; Depression; Drugs, Generic; Female; Health Care Costs; Humans; Male; Middle Aged; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; United Kingdom; Venlafaxine Hydrochloride; Young Adult

2010
The venlafaxine "heart revenge:" a short report.
    Clinical cardiology, 2010, Volume: 33, Issue:4

    Topics: Adult; Antidepressive Agents, Second-Generation; Coronary Angiography; Creatine Kinase; Cyclohexanols; Depression; Drug Overdose; Electrocardiography; Fatal Outcome; Female; Humans; Myocardial Infarction; Oxygen; Suicide, Attempted; Troponin I; Venlafaxine Hydrochloride

2010
Physician speciality and pain reduction in patients with depressive symptoms under treatment with venlafaxine.
    European psychiatry : the journal of the Association of European Psychiatrists, 2010, Volume: 25, Issue:8

    Topics: Adult; Aged; Analgesics; Analysis of Variance; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Depressive Disorder; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Pain Perception; Physicians; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride

2010
Broken heart syndrome: Tako Tsubo cardiomyopathy associated with an overdose of the serotonin-norepinephrine reuptake inhibitor Venlafaxine.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2010, Volume: 20, Issue:8

    Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Drug Overdose; Echocardiography; Female; Humans; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Takotsubo Cardiomyopathy; Venlafaxine Hydrochloride

2010
Antidepressant-like effect of venlafaxine is abolished in μ-opioid receptor-knockout mice.
    Journal of pharmacological sciences, 2010, Volume: 114, Issue:1

    Topics: Animals; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, Opioid, mu; Swimming; Venlafaxine Hydrochloride

2010
Association between antidepressant use during pregnancy and infants born small for gestational age.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2010, Volume: 55, Issue:10

    Topics: Adolescent; Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Canada; Case-Control Studies; Confounding Factors, Epidemiologic; Cyclohexanols; Depression; Female; Humans; Infant, Newborn; Infant, Small for Gestational Age; Middle Aged; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Second; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride

2010
The antidepressant action of imipramine and venlafaxine involves suppression of nitric oxide synthesis.
    Behavioural brain research, 2011, Mar-17, Volume: 218, Issue:1

    Topics: Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Cyclohexanols; Depression; Disease Models, Animal; Imipramine; Male; Mice; Mice, Inbred C57BL; Motor Activity; Nitric Oxide; Swimming; Venlafaxine Hydrochloride

2011
Evaluation of antidepressant activity of 1-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-YL)-cyclohexanol, a β-substituted phenylethylamine in mice.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2011, Volume: 21, Issue:9

    Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Behavior, Animal; Biogenic Amines; Brain; Cyclohexanols; Depression; Disease Models, Animal; Hindlimb Suspension; Hypnotics and Sedatives; Isoquinolines; Male; Mice; Motor Activity; Neurotransmitter Agents; Pentobarbital; Reserpine; Sleep; Swimming; Venlafaxine Hydrochloride

2011
Venlafaxine modulates depression-induced behaviour and the expression of Bax mRNA and Bcl-xl mRNA in both hippocampus and myocardium.
    Human psychopharmacology, 2011, Volume: 26, Issue:2

    Topics: Animals; bcl-2-Associated X Protein; bcl-X Protein; Cyclohexanols; Depression; Gene Expression Regulation; Hippocampus; Male; Myocardium; Random Allocation; Rats; Rats, Sprague-Dawley; RNA, Messenger; Stress, Psychological; Venlafaxine Hydrochloride

2011
Hippocampal CA3 calcineurin activity participates in depressive-like behavior in rats.
    Journal of neurochemistry, 2011, Volume: 117, Issue:6

    Topics: Animals; Antidepressive Agents; Behavior, Animal; Bridged Bicyclo Compounds; CA3 Region, Hippocampal; Calcineurin; Calcineurin Inhibitors; Cyclohexanols; Cyclosporine; Depression; Haloperidol; Male; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Stress, Psychological; Venlafaxine Hydrochloride

2011
Metabonomic study on chronic unpredictable mild stress and intervention effects of Xiaoyaosan in rats using gas chromatography coupled with mass spectrometry.
    Journal of ethnopharmacology, 2011, Sep-01, Volume: 137, Issue:1

    Topics: Animals; Antidepressive Agents; Behavior, Animal; Biomarkers; Body Weight; Chronic Disease; Cyclohexanols; Depression; Disease Models, Animal; Drugs, Chinese Herbal; Food Preferences; Gas Chromatography-Mass Spectrometry; Male; Metabolomics; Motor Activity; Principal Component Analysis; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Stress, Psychological; Venlafaxine Hydrochloride

2011
Effects of venlafaxine and escitalopram treatments on NMDA receptors in the rat depression model.
    The Journal of membrane biology, 2011, Volume: 242, Issue:3

    Topics: Animals; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depression; Disease Models, Animal; Hippocampus; Male; Random Allocation; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Venlafaxine Hydrochloride

2011
Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response.
    Molecular psychiatry, 2012, Volume: 17, Issue:9

    Topics: Action Potentials; Animals; Antidepressive Agents, Second-Generation; Anxiety; Brain; Corticosterone; Cyclohexanols; Depression; Disease Models, Animal; Female; Hippocampus; Limbic System; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Imaging; Norepinephrine; Organic Cation Transport Proteins; Organic Cation Transporter 2; Radioligand Assay; Serotonin; Venlafaxine Hydrochloride

2012
Venlafaxine protects against stress-induced oxidative DNA damage in hippocampus during antidepressant testing in mice.
    Pharmacology, biochemistry, and behavior, 2011, Volume: 100, Issue:1

    Topics: Animals; Antidepressive Agents; Cyclohexanols; Depression; DNA Damage; Hippocampus; Male; Mice; Oxidative Stress; Random Allocation; Stress, Psychological; Venlafaxine Hydrochloride

2011
[Approximate entropy of the placebo effect in clinical trials of newer antidepressants].
    Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina), 2010, Volume: 67, Issue:4

    Topics: Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cyclohexanols; Depression; Fluoxetine; Humans; Paroxetine; Placebo Effect; Placebos; Severity of Illness Index; Venlafaxine Hydrochloride

2010
Antidepressant-like effect of 1-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-YL)-cyclohexanol, a putative trace amine receptor ligand involves l-arginine-nitric oxide-cyclic guanosine monophosphate pathway.
    Neuroscience letters, 2011, Oct-03, Volume: 503, Issue:2

    Topics: Analysis of Variance; Animals; Antidepressive Agents; Arginine; Biogenic Amines; Brain Chemistry; Cyclic GMP; Cyclohexanols; Depression; Guanylate Cyclase; Indazoles; Isoquinolines; Male; Methylene Blue; Mice; Motor Activity; Neurotransmitter Agents; Nitric Oxide; Nitric Oxide Synthase; Phosphodiesterase Inhibitors; Piperazines; Purines; Signal Transduction; Sildenafil Citrate; Sulfones; Swimming

2011
Association between antidepressant use during pregnancy and infants born small for gestational age.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2011, Volume: 56, Issue:8

    Topics: Antidepressive Agents; Cyclohexanols; Depression; Female; Humans; Infant, Small for Gestational Age; Pregnancy; Pregnancy Complications

2011
[Effect of venlafaxine on cognitive function and hippocampal brain-derived neurotrophic factor expression in rats with post-stroke depression].
    Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2011, Volume: 40, Issue:5

    Topics: Animals; Brain-Derived Neurotrophic Factor; Cyclohexanols; Depression; Disease Models, Animal; Hippocampus; Male; Maze Learning; Memory; Memory Disorders; Rats; Rats, Sprague-Dawley; Stroke; Venlafaxine Hydrochloride

2011
Long lasting effects of early-life stress on glutamatergic/GABAergic circuitry in the rat hippocampus.
    Neuropharmacology, 2012, Volume: 62, Issue:5-6

    Topics: Age Factors; Animals; Antidepressive Agents, Second-Generation; Corticosterone; Cyclohexanols; Depression; Excitatory Amino Acid Transporter 1; Female; GABA Plasma Membrane Transport Proteins; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Glutamic Acid; Hippocampus; Male; Maternal Deprivation; Nerve Net; Neurons; Rats; Venlafaxine Hydrochloride

2012
The analysis of binary longitudinal data with time-dependent covariates.
    Statistics in medicine, 2012, May-10, Volume: 31, Issue:10

    Topics: Antidepressive Agents, Second-Generation; Computer Simulation; Cyclohexanols; Data Interpretation, Statistical; Depression; Humans; Likelihood Functions; Lithium; Logistic Models; Longitudinal Studies; Regression Analysis; Venlafaxine Hydrochloride

2012
Selective serotonin reuptake inhibitors, venlafaxine and duloxetine are associated with in hospital morbidity but not bleeding or late mortality after coronary artery bypass graft surgery.
    Heart, lung & circulation, 2012, Volume: 21, Issue:4

    Topics: Aged; Aged, 80 and over; Australia; Coronary Artery Bypass; Coronary Artery Disease; Cyclohexanols; Depression; Duloxetine Hydrochloride; Female; Follow-Up Studies; Hospital Mortality; Humans; Kidney Diseases; Male; Middle Aged; Postoperative Hemorrhage; Proportional Hazards Models; Renal Dialysis; Respiration, Artificial; Selective Serotonin Reuptake Inhibitors; Thiophenes; Time Factors; Venlafaxine Hydrochloride

2012
Antidepressant-like effect of the ethanolic extract from Suanzaorenhehuan Formula in mice models of depression.
    Journal of ethnopharmacology, 2012, May-07, Volume: 141, Issue:1

    Topics: Animals; Antidepressive Agents; Behavior, Animal; Chemical Fractionation; Cyclohexanols; Depression; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Ethanol; Hippocampus; Male; Mice; Mice, Inbred ICR; Monoamine Oxidase; Motor Activity; Norepinephrine; Phytotherapy; Plants, Medicinal; Prefrontal Cortex; Serotonin; Solvents; Time Factors; Venlafaxine Hydrochloride

2012
Hypoglycaemia: a little known effect of Venlafaxine overdose.
    Clinical toxicology (Philadelphia, Pa.), 2012, Volume: 50, Issue:3

    Topics: Adult; Alprazolam; Analgesics; Anti-Anxiety Agents; Cyclohexanols; Depression; Drug Overdose; Drug Therapy, Combination; Female; Gastrointestinal Agents; Half-Life; Humans; Hypoglycemia; Octreotide; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Treatment Outcome; Venlafaxine Hydrochloride

2012
Anti-depressant effects of Xiaoyaosan on rat model of chronic unpredictable mild stress: a plasma metabonomics study based on NMR spectroscopy.
    The Journal of pharmacy and pharmacology, 2012, Volume: 64, Issue:4

    Topics: Animals; Antidepressive Agents; Behavior, Animal; Biomarkers; Chronic Disease; Cyclohexanols; Depression; Disease Models, Animal; Drugs, Chinese Herbal; Fluoxetine; Magnetic Resonance Spectroscopy; Male; Metabolomics; Motor Activity; Multivariate Analysis; Rats; Rats, Sprague-Dawley; Stress, Psychological; Sucrose; Venlafaxine Hydrochloride

2012
Long-lasting effects of chronic rTMS to treat chronic rodent model of depression.
    Behavioural brain research, 2012, Jun-15, Volume: 232, Issue:1

    Topics: Adrenocorticotropic Hormone; Anhedonia; Animals; Antidepressive Agents, Second-Generation; Antimetabolites; Blotting, Western; Body Weight; Brain; Brain-Derived Neurotrophic Factor; Bromodeoxyuridine; Cyclohexanols; Depression; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Food Preferences; Hydrocortisone; Male; MAP Kinase Signaling System; Motor Activity; Neurogenesis; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Stress, Psychological; Swimming; Transcranial Magnetic Stimulation; Venlafaxine Hydrochloride

2012
Chronic social defeat stress model: behavioral features, antidepressant action, and interaction with biological risk factors.
    Psychopharmacology, 2012, Volume: 224, Issue:2

    Topics: Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Cyclohexanols; Depression; Depressive Disorder; Disease Models, Animal; Fluoxetine; Male; Mice; Mice, Inbred C57BL; Risk Factors; RNA, Messenger; Social Behavior; Stress, Psychological; Thiazepines; Venlafaxine Hydrochloride; Vesicular Glutamate Transport Protein 1

2012
Inhibition of calcineurin in the prefrontal cortex induced depressive-like behavior through mTOR signaling pathway.
    Psychopharmacology, 2013, Volume: 225, Issue:2

    Topics: Animals; Antidepressive Agents, Second-Generation; Calcineurin Inhibitors; Cyclohexanols; Cyclosporine; Depression; Disease Models, Animal; Immunosuppressive Agents; Male; Microinjections; Phosphorylation; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Ribosomal Protein S6; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sucrose; Tacrolimus; TOR Serine-Threonine Kinases; Venlafaxine Hydrochloride

2013
Plasma exchange in the management of a case of hypertriglyceridaemic pancreatitis triggered by venlafaxine.
    BMJ case reports, 2012, Aug-14, Volume: 2012

    Topics: Adult; Cyclohexanols; Depression; Diagnosis, Differential; Fluid Therapy; Humans; Hypertriglyceridemia; Male; Pancreatitis, Acute Necrotizing; Plasma Exchange; Selective Serotonin Reuptake Inhibitors; Tomography, X-Ray Computed; Venlafaxine Hydrochloride

2012
Venlafaxine causing akathisia: a case report.
    The Journal of neuropsychiatry and clinical neurosciences, 2012,Summer, Volume: 24, Issue:3

    Topics: Aged; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Humans; Male; Venlafaxine Hydrochloride

2012
Venlafaxine augmentation with lithium leading to serotonin syndrome.
    The Journal of neuropsychiatry and clinical neurosciences, 2012,Summer, Volume: 24, Issue:3

    Topics: Aged; Cyclohexanols; Depression; Drug Synergism; Humans; Lithium Chloride; Male; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Venlafaxine Hydrochloride

2012
Venlafaxine and risk of upper gastrointestinal bleeding in elderly depression.
    Current drug safety, 2012, Nov-01, Volume: 7, Issue:5

    Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Female; Gastrointestinal Hemorrhage; Humans; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride

2012
Differences in clinician understanding and management of early menopause after breast cancer.
    Climacteric : the journal of the International Menopause Society, 2013, Volume: 16, Issue:4

    Topics: Anxiety; Australia; Breast Neoplasms; Cross-Sectional Studies; Cyclohexanols; Depression; Endocrinology; Exercise; Female; Follicle Stimulating Hormone; General Practitioners; General Surgery; Gynecology; Hot Flashes; Humans; Life Style; Medical Oncology; Menopause, Premature; Practice Patterns, Physicians'; Surveys and Questionnaires; Venlafaxine Hydrochloride

2013
Biochemical mechanism studies of venlafaxine by metabonomic method in rat model of depression.
    European review for medical and pharmacological sciences, 2013, Volume: 17, Issue:1

    Topics: Animals; Antidepressive Agents, Second-Generation; Biogenic Monoamines; Brain; Cyclohexanols; Depression; Disease Models, Animal; Male; Metabolomics; Neurotransmitter Agents; Rats; Rats, Sprague-Dawley; Venlafaxine Hydrochloride

2013
[Delirium during withdrawal of venlafaxine].
    Nederlands tijdschrift voor geneeskunde, 2002, Jun-29, Volume: 146, Issue:26

    Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Delirium; Depression; Drug Administration Schedule; Half-Life; Humans; Male; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride

2002
Interaction between ECT and venlafaxine.
    International journal of geriatric psychiatry, 2002, Volume: 17, Issue:10

    Topics: Aged; Antidepressive Agents, Second-Generation; Antihypertensive Agents; Atenolol; Combined Modality Therapy; Cyclohexanols; Depression; Electroconvulsive Therapy; Fatal Outcome; Female; Humans; Hypertension; Venlafaxine Hydrochloride

2002
Diffusion of new generation antidepressant treatment among elderly diagnosed with depression.
    Medical care, 2003, Volume: 41, Issue:1

    Topics: Age Factors; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Comorbidity; Cyclohexanols; Depression; Diabetes Mellitus; Fee-for-Service Plans; Female; Health Status; Heart Diseases; Humans; Hypertension; Male; Medicare; Monoamine Oxidase Inhibitors; Multivariate Analysis; Racial Groups; Sample Size; Sampling Studies; Selective Serotonin Reuptake Inhibitors; Sex Factors; Socioeconomic Factors; Venlafaxine Hydrochloride

2003
[Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy].
    Nederlands tijdschrift voor geneeskunde, 2003, Jul-12, Volume: 147, Issue:28

    Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Female; Humans; Infant, Newborn; Male; Neonatal Abstinence Syndrome; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride

2003
Mania associated with venlafaxine discontinuation.
    The international journal of neuropsychopharmacology, 2003, Volume: 6, Issue:1

    Topics: Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depression; Humans; Male; Middle Aged; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride

2003
Risperidone-responsive segmental dystonia and pallidal deep brain stimulation.
    Neurology, 2003, Aug-26, Volume: 61, Issue:4

    Topics: Aged; Antidepressive Agents; Combined Modality Therapy; Cyclohexanols; Depression; Dopamine Antagonists; Dystonic Disorders; Electric Stimulation Therapy; Globus Pallidus; Humans; Male; Parkinson Disease, Secondary; Risperidone; Severity of Illness Index; Venlafaxine Hydrochloride

2003
Mirtazapine-induced hyponatraemia.
    The Medical journal of Australia, 2003, Oct-20, Volume: 179, Issue:8

    Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depression; Female; Humans; Hyponatremia; Mianserin; Mirtazapine; Venlafaxine Hydrochloride

2003
Hypertensive crisis associated with venlafaxine.
    The American journal of medicine, 2003, Dec-01, Volume: 115, Issue:8

    Topics: Adult; Alcohol Deterrents; Alcoholism; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depression; Disulfiram; Drug Interactions; Humans; Hypertension; Venlafaxine Hydrochloride

2003
Venlafaxine-induced depression of wind-up activity in mononeuropathic rats is potentiated by inhibition of brain 5-HT1A receptor expression in vivo.
    The International journal of neuroscience, 2004, Volume: 114, Issue:2

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Behavior, Animal; Body Temperature; Cyclohexanols; Depression; Dose-Response Relationship, Drug; Drug Synergism; Fever; Hyperalgesia; Infusion Pumps, Implantable; Male; Oligonucleotides, Antisense; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Reflex; Regression, Psychology; Sciatic Neuropathy; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Antagonists; Time Factors; Venlafaxine Hydrochloride

2004
Massive venlafaxine overdose resulted in a false positive Abbott AxSYM urine immunoassay for phencyclidine.
    Journal of toxicology. Clinical toxicology, 2003, Volume: 41, Issue:7

    Topics: Adolescent; Cyclohexanols; Depression; Drug Overdose; False Positive Reactions; Female; Gas Chromatography-Mass Spectrometry; Humans; Immunoassay; Phencyclidine; Venlafaxine Hydrochloride

2003
Is Effexor more effective for depression than an SSRI?
    The Medical letter on drugs and therapeutics, 2004, Feb-16, Volume: 46, Issue:1176

    Topics: Cyclohexanols; Depression; Humans; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride

2004
Very low dose quetiapine-induced galactorrhea in combination with venlafaxine.
    Human psychopharmacology, 2004, Volume: 19, Issue:6

    Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Cyclohexanols; Depression; Dibenzothiazepines; Drug Synergism; Drug Therapy, Combination; Female; Galactorrhea; Humans; Prolactin; Quetiapine Fumarate; Venlafaxine Hydrochloride

2004
Drugs vs. talk therapy: 3,079 readers rate their care for depression and anxiety.
    Consumer reports, 2004, Volume: 69, Issue:10

    Topics: Antidepressive Agents; Anxiety; Anxiety Disorders; Bupropion; Citalopram; Cyclohexanols; Depression; Drug Therapy; Fluoxetine; Humans; Paroxetine; Patient Satisfaction; Primary Health Care; Psychiatry; Psychology; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Sertraline; Social Work

2004
Spontaneous orgasm started with venlafaxine and continued with citalopram.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2004, Volume: 49, Issue:11

    Topics: Ambulatory Care; Antidepressive Agents, Second-Generation; Citalopram; Combined Modality Therapy; Cyclohexanols; Depression; Electroconvulsive Therapy; Female; Humans; Middle Aged; Orgasm; Patient Admission; Venlafaxine Hydrochloride

2004
Bilateral acute angle closure caused by supraciliary effusions associated with venlafaxine intake.
    The Medical journal of Australia, 2005, Feb-07, Volume: 182, Issue:3

    Topics: Adult; Antidepressive Agents, Second-Generation; Antihypertensive Agents; Anxiety; Ciliary Body; Cyclohexanols; Depression; Glaucoma, Angle-Closure; Gonioscopy; Humans; Iris; Male; Microscopy, Acoustic; Ocular Hypertension; Venlafaxine Hydrochloride

2005
Effects of extract of Ginkgo biloba with venlafaxine on brain injury in a rat model of depression.
    Chinese medical journal, 2005, Mar-05, Volume: 118, Issue:5

    Topics: Animals; Antidepressive Agents, Second-Generation; Brain Injuries; Brain-Derived Neurotrophic Factor; Cyclohexanols; Depression; Drugs, Chinese Herbal; Ginkgo biloba; Hippocampus; Male; Phytotherapy; Rats; Rats, Wistar; Venlafaxine Hydrochloride

2005
Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI).
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2005, Jun-05, Volume: 820, Issue:1

    Topics: Antidepressive Agents, Tricyclic; Chromatography, High Pressure Liquid; Citalopram; Cyclohexanols; Depression; Female; Fluoxetine; Humans; Male; Paroxetine; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Venlafaxine Hydrochloride

2005
Impact of venlafaxine on gene expression profile in lymphocytes of the elderly with major depression--evolution of antidepressants and the role of the "neuro-immune" system.
    Neurochemical research, 2005, Volume: 30, Issue:11

    Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Female; Gene Expression Profiling; Humans; Lymphocytes; Male; Molecular Sequence Data; Neuroimmunomodulation; Oligonucleotide Array Sequence Analysis; Reproducibility of Results; Venlafaxine Hydrochloride

2005
Assessment of Canadian provincial expenditures in depressed patients treated with venlafaxine XR versus SSRIs: the APEX Study.
    Current medical research and opinion, 2006, Volume: 22, Issue:1

    Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Canada; Cyclohexanols; Depression; Direct Service Costs; Female; Health Expenditures; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride

2006
QT interval prolongation associated with venlafaxine administration.
    International journal of cardiology, 2006, Apr-28, Volume: 109, Issue:1

    Topics: Cyclohexanols; Depression; Electrocardiography; Female; Heart Conduction System; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride

2006
The influence of tobacco smoke and nicotine on antidepressant and memory-improving effects of venlafaxine.
    Human & experimental toxicology, 2006, Volume: 25, Issue:4

    Topics: Animals; Antidepressive Agents, Second-Generation; Atmosphere Exposure Chambers; Behavior, Animal; Cyclohexanols; Depression; Female; Maze Learning; Memory; Motor Activity; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Smoking; Swimming; Venlafaxine Hydrochloride

2006
Dose-dependent Venlafaxine-induced sinus tachycardia.
    International journal of cardiology, 2006, Oct-26, Volume: 113, Issue:1

    Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Dose-Response Relationship, Drug; Female; Humans; Tachycardia, Sinus; Venlafaxine Hydrochloride

2006
High performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI) method for simultaneous determination of venlafaxine and its three metabolites in human plasma.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007, May-01, Volume: 850, Issue:1-2

    Topics: Antidepressive Agents, Second-Generation; Calibration; Chromatography, High Pressure Liquid; Cyclohexanols; Depression; Female; Humans; Male; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Venlafaxine Hydrochloride

2007
Venlafaxine modulates depression-induced oxidative stress in brain and medulla of rat.
    Neurochemical research, 2007, Volume: 32, Issue:3

    Topics: Animals; Antidepressive Agents, Second-Generation; Antioxidants; Brain; Cerebral Cortex; Cyclohexanols; Depression; Disease Models, Animal; Housing, Animal; Lipid Peroxidation; Male; Medulla Oblongata; Nitric Oxide; Oxidative Stress; Rats; Rats, Wistar; Venlafaxine Hydrochloride; Water Deprivation

2007
Involvement of sigma-1 receptor modulation in the antidepressant action of venlafaxine.
    Neuroscience letters, 2007, Jun-15, Volume: 420, Issue:3

    Topics: Analgesics, Opioid; Animals; Antidepressive Agents, Second-Generation; Carbazoles; Cyclohexanols; Depression; Dose-Response Relationship, Drug; Ethylenediamines; Male; Mice; Motor Activity; Neuroprotective Agents; Pentazocine; Receptors, sigma; Sigma-1 Receptor; Swimming; Venlafaxine Hydrochloride

2007
A case series of increased libido and spontaneous orgasm associated with venlafaxine treatment.
    Progress in neuro-psychopharmacology & biological psychiatry, 2008, Apr-01, Volume: 32, Issue:3

    Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Female; Humans; Libido; Orgasm; Venlafaxine Hydrochloride

2008
[Velaxin (venlafaxine) in the treatment of anxious depression].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2008, Volume: 108, Issue:3

    Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depression; Female; Humans; Inpatients; Male; Middle Aged; Outpatients; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride

2008
Desvenlafaxine for depression.
    The Medical letter on drugs and therapeutics, 2008, May-19, Volume: 50, Issue:1286

    Topics: Antidepressive Agents; Cyclohexanols; Depression; Depressive Disorder, Major; Desvenlafaxine Succinate; Drug Interactions; Humans; Neurotransmitter Uptake Inhibitors

2008
Venlafaxine marketed as antidepressant.
    American journal of hospital pharmacy, 1994, Jul-01, Volume: 51, Issue:13

    Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Humans; Selective Serotonin Reuptake Inhibitors; Tablets; Venlafaxine Hydrochloride

1994
Hyponatremia with venlafaxine.
    The Annals of pharmacotherapy, 1998, Volume: 32, Issue:1

    Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Female; Humans; Hyponatremia; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride

1998
[Pharma-Clinics. The drug of the month. Venlafaxine (Efexor)].
    Revue medicale de Liege, 1998, Volume: 53, Issue:2

    Topics: Antidepressive Agents, Second-Generation; Blood Pressure; Cyclohexanols; Depression; Drug Administration Schedule; Humans; Hypertension; Nausea; Selective Serotonin Reuptake Inhibitors; Therapeutic Equivalency; Venlafaxine Hydrochloride

1998
Venlafaxine withdrawal reactions.
    The Medical journal of Australia, 1998, Jul-20, Volume: 169, Issue:2

    Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Cyclohexanols; Depression; Depressive Disorder; Dizziness; Fatigue; Female; Hallucinations; Headache; Humans; Male; Middle Aged; Nausea; Sensation Disorders; Substance Withdrawal Syndrome; Tinnitus; Venlafaxine Hydrochloride

1998
Blockade of 5-hydroxytryptamine and noradrenaline uptake by venlafaxine: a comparative study with paroxetine and desipramine.
    British journal of pharmacology, 1998, Volume: 125, Issue:3

    Topics: Adrenergic Uptake Inhibitors; Animals; Cyclohexanols; Depression; Desipramine; Hippocampus; Injections, Intravenous; Iontophoresis; Male; Norepinephrine; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride

1998
Venlafaxine in the treatment of resistant postpsychotic depressive symptoms of schizophrenia.
    Journal of clinical psychopharmacology, 1999, Volume: 19, Issue:3

    Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Drug Resistance; Humans; Male; Middle Aged; Schizophrenia; Venlafaxine Hydrochloride

1999
Diaphoresis and pruritus with extended-release venlafaxine.
    The Annals of pharmacotherapy, 1999, Volume: 33, Issue:9

    Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depression; Female; Humans; Pruritus; Sweating; Venlafaxine Hydrochloride

1999
Antidepressant-induced bruxism successfully treated with gabapentin.
    Journal of the American Dental Association (1939), 1999, Volume: 130, Issue:10

    Topics: Acetates; Amines; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Bipolar Disorder; Bruxism; Cyclohexanecarboxylic Acids; Cyclohexanols; Depression; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Venlafaxine Hydrochloride

1999
Priapism associated with venlafaxine use.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2000, Volume: 39, Issue:1

    Topics: Adolescent; Cyclohexanols; Depression; Humans; Male; Priapism; Recurrence; Selective Serotonin Reuptake Inhibitors; Substance-Related Disorders; Venlafaxine Hydrochloride

2000
Venlafaxine and paroxetine in treatment-resistant depression.
    The British journal of psychiatry : the journal of mental science, 1999, Volume: 175

    Topics: Cyclohexanols; Depression; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride

1999
Generalized anxiety disorder in family practice patients.
    American family physician, 2000, Oct-01, Volume: 62, Issue:7

    Topics: Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Cyclohexanols; Depression; Diagnosis, Differential; Family Practice; Humans; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; United States; Venlafaxine Hydrochloride

2000
Prefrontal changes and treatment response prediction in depression.
    Seminars in clinical neuropsychiatry, 2001, Volume: 6, Issue:2

    Topics: Adult; Antidepressive Agents; Cyclohexanols; Depression; Depressive Disorder, Major; Electroencephalography; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Prefrontal Cortex; Sertraline; Venlafaxine Hydrochloride

2001
The reductions in sweetened milk intake induced by interleukin-1 and endotoxin are not prevented by chronic antidepressant treatment.
    Neuroimmunomodulation, 2001, Volume: 9, Issue:3

    Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Appetite; Body Weight; Brain; Cyclohexanols; Depression; Dose-Response Relationship, Drug; Drug Administration Schedule; Eating; Imipramine; Interleukin-1; Lipopolysaccharides; Male; Mice; Milk; Neuroimmunomodulation; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride

2001
Treatment of psychotic depression associated with steroid therapy in Churg-Strauss syndrome.
    Irish medical journal, 2002, Volume: 95, Issue:1

    Topics: Adrenal Cortex Hormones; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Churg-Strauss Syndrome; Cyclohexanols; Depression; Electroconvulsive Therapy; Female; Humans; Middle Aged; Paroxetine; Risperidone; Venlafaxine Hydrochloride

2002
[Family physician's interventions and prescribing practice. Results of the GAD-P study].
    Fortschritte der Medizin. Originalien, 2001, Volume: 119 Suppl 1

    Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety Disorders; Barbiturates; Behavior Therapy; Cyclohexanols; Depression; Female; Humans; Hypnotics and Sedatives; Male; Physicians, Family; Phytotherapy; Referral and Consultation; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride

2001
An open-label, variable-dose study of WY-45,030 (venlafexine) in depressed outpatients.
    Psychopharmacology bulletin, 1988, Volume: 24, Issue:1

    Topics: Adult; Aged; Antidepressive Agents; Cyclohexanols; Depression; Female; Humans; Male; Middle Aged; Outpatients; Venlafaxine Hydrochloride

1988